
Harvard Bioscience HBIO
$ 6.18
2.32%
Quarterly report 2026-Q1
added 05-12-2026
Harvard Bioscience Total Inventories 2011-2026 | HBIO
Annual Total Inventories Harvard Bioscience
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 20.8 M | 23.2 M | 24.7 M | 26.4 M | 27.6 M | 22.3 M | 22.1 M | 25.1 M | 21.4 M | 20 M | 22.3 M | 20.5 M | 15.8 M | 17.8 M | 18.2 M | 15.8 M | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 27.6 M | 15.8 M | 21.5 M |
Quarterly Total Inventories Harvard Bioscience
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 22.2 M | 21.6 M | 22.3 M | 22.8 M | 23.2 M | 26 M | 25.1 M | 24.1 M | 24.7 M | 25.8 M | 26.1 M | 26.9 M | 26.4 M | - | - | 28.7 M | 27.6 M | 26 M | 24.7 M | 22.7 M | 22.3 M | 22.3 M | 22.3 M | 22.3 M | 22.1 M | 22.1 M | 22.1 M | 22.1 M | 25.1 M | 25.1 M | 25.1 M | 25.1 M | 16.8 M | 16.8 M | 16.8 M | 16.8 M | 20 M | 20 M | 20 M | 20 M | 22.3 M | 22.3 M | 22.3 M | 22.3 M | 20.5 M | 20.5 M | 20.5 M | 20.5 M | 15.8 M | 15.8 M | 18.3 M | 15.8 M | 17.8 M | 17.8 M | 17.8 M | 17.8 M | 18.2 M | 18.2 M | 18.2 M | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 28.7 M | 15.8 M | 21.7 M |
Total Inventories of other stocks in the Medical instruments industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
82.3 M | - | - | $ 810 M | ||
|
The Cooper Companies
COO
|
846 M | $ 67.92 | -1.02 % | $ 13.5 B | ||
|
Glaukos Corporation
GKOS
|
63.6 M | $ 122.21 | -3.34 % | $ 6.99 B | ||
|
Intuitive Surgical
ISRG
|
1.84 B | $ 417.12 | -2.22 % | $ 149 B | ||
|
ICU Medical
ICUI
|
616 M | $ 142.83 | 0.58 % | $ 3.52 B | ||
|
Repro Med Systems
KRMD
|
3.68 M | $ 3.97 | -0.88 % | $ 183 M | ||
|
iRhythm Technologies
IRTC
|
21.6 M | $ 114.34 | 0.45 % | $ 3.66 B | ||
|
LeMaitre Vascular
LMAT
|
19.6 M | $ 93.85 | -2.84 % | $ 2.12 B | ||
|
Masimo Corporation
MASI
|
459 M | $ 179.95 | - | $ 9.59 B | ||
|
Microbot Medical
MBOT
|
584 K | $ 1.8 | -1.1 % | $ 82.4 M | ||
|
Ekso Bionics Holdings
EKSO
|
4.82 M | - | - | $ 28.6 M | ||
|
Milestone Scientific
MLSS
|
3.78 M | $ 0.4 | 2.43 % | $ 32.8 M | ||
|
Merit Medical Systems
MMSI
|
334 M | $ 67.35 | -0.24 % | $ 3.98 B | ||
|
electroCore
ECOR
|
1.63 M | $ 9.9 | 3.99 % | $ 84 K | ||
|
Envista Holdings Corporation
NVST
|
288 M | $ 24.52 | -0.28 % | $ 4.12 B | ||
|
Haemonetics Corporation
HAE
|
306 M | $ 79.32 | 0.74 % | $ 3.74 B | ||
|
STERIS plc
STE
|
632 M | $ 209.69 | -1.5 % | $ 20.6 B | ||
|
Isoray
ISR
|
1.41 M | - | 0.03 % | $ 108 M | ||
|
STAAR Surgical Company
STAA
|
15.7 M | $ 29.75 | -0.4 % | $ 1.47 B | ||
|
InfuSystem Holdings
INFU
|
5.39 M | $ 8.9 | -1.22 % | $ 184 M | ||
|
Teleflex Incorporated
TFX
|
404 M | $ 135.23 | -0.38 % | $ 6.03 B | ||
|
Utah Medical Products
UTMD
|
7.94 M | $ 68.56 | 0.72 % | $ 222 M | ||
|
West Pharmaceutical Services
WST
|
444 M | $ 330.41 | -1.35 % | $ 23.9 B | ||
|
Pulse Biosciences
PLSE
|
136 K | $ 25.17 | -2.33 % | $ 1.7 B | ||
|
DENTSPLY SIRONA
XRAY
|
642 M | $ 10.31 | -1.53 % | $ 2.06 B | ||
|
Retractable Technologies
RVP
|
17.2 M | $ 0.7 | 1.73 % | $ 21 M | ||
|
Pro-Dex
PDEX
|
22.2 M | $ 62.36 | -4.06 % | $ 205 M | ||
|
Predictive Oncology
POAI
|
45.8 K | - | - | $ 31.1 M | ||
|
BioLife Solutions
BLFS
|
30.2 M | $ 26.91 | -2.34 % | $ 1.29 B | ||
|
Stereotaxis
STXS
|
9.57 M | $ 1.84 | -0.54 % | $ 167 M | ||
|
Baxter International
BAX
|
2.23 B | $ 20.49 | 2.3 % | $ 10.5 B | ||
|
ResMed
RMD
|
744 M | $ 194.98 | -1.0 % | $ 28.5 B | ||
|
AtriCure
ATRC
|
78.5 M | $ 27.26 | -0.15 % | $ 1.3 B | ||
|
NeuroMetrix
NURO
|
1.35 M | - | 5.05 % | $ 9.02 M | ||
|
AngioDynamics
ANGO
|
62 M | $ 12.39 | 0.36 % | $ 506 M | ||
|
Becton, Dickinson and Company
BDX
|
3.89 B | $ 149.8 | -1.48 % | $ 43.1 B | ||
|
Nephros
NEPH
|
3.23 M | $ 3.24 | -0.46 % | $ 34.4 M | ||
|
OraSure Technologies
OSUR
|
31.1 M | $ 4.09 | -3.66 % | $ 301 M | ||
|
Repligen Corporation
RGEN
|
170 M | $ 132.62 | 1.91 % | $ 7.46 M |